학술논문

A randomized, open-label, comparative, crossover trial on preference, efficacy, and safety profiles of lispro insulin u-100 versus concentrated lispro insulin u-200 in patients with type 2 diabetes mellitus: a possible contribution to greater treatment adherence
Document Type
Article
Source
In: Expert Opinion on Drug Safety. (Expert Opinion on Drug Safety, 4 May 2018, 17(5):445-450)
Subject
Language
English
ISSN
1744764X
14740338